Nordic Bioscience is a biomarker company focused on improving drug development through mechanism-based biomarker solutions for chronic diseases. Using its proprietary Nordic ProteinFingerPrint Technology™, the company identifies specific extracellular matrix protein fragments released from diseased tissue and translates them into blood-based biomarker assays for disease activity assessment, prognosis, patient stratification, and treatment response evaluation. Nordic Bioscience supports research across multiple therapeutic areas and highlights a portfolio of more than 100 biomarkers, along with extensive scientific validation and regulatory experience in biomarker development.

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of Nordic Bioscience products.

⇨ Inquire or Order immediately ⇦

●Cancer Biomarkers

Nordic Bioscience offers non-invasive immunoactivity and fibrosis-related biomarkers for oncology research, with particular strength in tumor fibrosis and so-called hot and cold fibrotic tumor biology. These biomarkers are designed to support the assessment of tumor microenvironment remodeling and improve translational understanding in cancer studies. 

●Cardiovascular Biomarkers

Its cardiovascular biomarker portfolio supports research in myocardial infarction, atherosclerosis, heart failure, and HFpEF. These biomarkers are intended to provide insights into disease pathways, tissue remodeling, progression, and treatment response in cardiovascular studies. 

●Dermatology Biomarkers

Nordic Bioscience provides dermatology biomarkers for a range of skin diseases, including atopic dermatitis, hidradenitis suppurativa, psoriasis, and scleroderma. These assays are used to study disease activity, tissue remodeling, and therapeutic effects in dermatological research. 

●Gastrointestinal Biomarkers

The company offers a broad gastrointestinal biomarker portfolio, including markers relevant to ulcerative colitis and Crohn’s disease. These biomarkers are designed to support non-invasive assessment of disease activity and inflammatory tissue remodeling in GI disorders. 

●Kidney Biomarkers

Nordic Bioscience’s kidney biomarkers are designed to assess fibrosis and tissue remodeling across kidney diseases. They are positioned as useful tools for evaluating disease severity, identifying patients at higher risk of progression, and supporting treatment response studies. 

●Liver Biomarkers

Its liver biomarkers are developed for fibrotic liver diseases and related conditions, including MASH, MASLD, viral liver disease, immune-mediated liver disease, alcohol-related liver disease, and liver cancer. These assays are intended to support disease monitoring, prognosis, and treatment evaluation in hepatology research. 

●Respiratory Biomarkers

Nordic Bioscience provides respiratory biomarkers for the assessment of chronic lung diseases, including COPD, pulmonary fibrosis, and idiopathic pulmonary fibrosis. These biomarkers focus on mechanism-of-action readouts and tissue remodeling processes relevant to pulmonary research and drug development. 

●Neuroscience Biomarkers

The company also offers neuroscience-related biomarkers covering diseases such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. These biomarkers are intended to support studies of neurodegeneration, disease progression, and treatment-associated biological changes. 

●Obesity and Metabolic Dysfunction Biomarkers

Nordic ProteinFingerPrint™ biomarkers can be used to quantify fibrogenesis and tissue remodeling activity in obesity, type 2 diabetes, and other metabolic disorders. These biomarkers are designed to support early risk assessment, prognosis, and objective monitoring of treatment response in metabolic disease populations. 

●Rheumatology Biomarkers

Nordic Bioscience has longstanding experience in biomarker development for rheumatoid arthritis, osteoarthritis, and other arthritic diseases. Its rheumatology biomarker portfolio is intended to support mechanistic research, disease monitoring, and therapeutic evaluation in joint disorders.

■ Product List